As of Jun 26
| +0.29 / +2.47%|
The 11 analysts offering 12-month price forecasts for Horizon Pharma PLC have a median target of 16.00, with a high estimate of 22.00 and a low estimate of 10.00. The median estimate represents a +33.11% increase from the last price of 12.02.
The current consensus among 11 polled investment analysts is to Buy stock in Horizon Pharma PLC. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.